Livrea P - Search Results

1

Combination treatment of Glatiramer Acetate and Minocycline affects phenotype expression of blood monocyte-derived dendritic cells in Multiple Sclerosis patients.

Ruggieri M, Pica C, Lia A, Zimatore GB, Modesto M, Di Liddo E, Specchio LM, Livrea P, Trojano M, Avolio C. Ruggieri M, et al. Among authors: livrea p. J Neuroimmunol. 2008 Jul 15;197(2):140-6. doi: 10.1016/j.jneuroim.2008.04.032. Epub 2008 Jun 13. J Neuroimmunol. 2008. PMID: 18555539

2

Post-receptorial mechanisms underlie functional disregulation of beta2-adrenergic receptors in lymphocytes from Multiple Sclerosis patients.

Giorelli M, Livrea P, Trojano M. Giorelli M, et al. Among authors: livrea p. J Neuroimmunol. 2004 Oct;155(1-2):143-9. doi: 10.1016/j.jneuroim.2004.05.013. J Neuroimmunol. 2004. PMID: 15342205

3

Glatiramer acetate in multiple sclerosis: a review.

Ruggieri M, Avolio C, Livrea P, Trojano M. Ruggieri M, et al. Among authors: livrea p. CNS Drug Rev. 2007 Summer;13(2):178-91. doi: 10.1111/j.1527-3458.2007.00010.x. CNS Drug Rev. 2007. PMID: 17627671 Free PMC article. Review.

4

Monocytes P2X7 purinergic receptor is modulated by glatiramer acetate in multiple sclerosis.

Caragnano M, Tortorella P, Bergami A, Ruggieri M, Livrea P, Specchio LM, Martino G, Trojano M, Furlan R, Avolio C. Caragnano M, et al. Among authors: livrea p. J Neuroimmunol. 2012 Apr;245(1-2):93-7. doi: 10.1016/j.jneuroim.2012.02.002. Epub 2012 Feb 26. J Neuroimmunol. 2012. PMID: 22370183

5

Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes.

Avolio C, Ruggieri M, Giuliani F, Liuzzi GM, Leante R, Riccio P, Livrea P, Trojano M. Avolio C, et al. Among authors: livrea p. J Neuroimmunol. 2003 Mar;136(1-2):46-53. doi: 10.1016/s0165-5728(03)00006-7. J Neuroimmunol. 2003. PMID: 12620642

6

Glatiramer acetate induces pro-apoptotic mechanisms involving Bcl-2, Bax and Cyt-c in peripheral lymphocytes from multiple sclerosis patients.

Ruggieri M, Avolio C, Scacco S, Pica C, Lia A, Zimatore GB, Papa S, Livrea P, Trojano M. Ruggieri M, et al. Among authors: livrea p. J Neurol. 2006 Feb;253(2):231-6. doi: 10.1007/s00415-005-0965-y. Epub 2005 Sep 30. J Neurol. 2006. PMID: 16184340

7

Differential regulation of membrane bound and soluble ICAM 1 in human endothelium and blood mononuclear cells: effects of interferon beta-1a.

Giorelli M, De Blasi A, Defazio G, Avolio C, Iacovelli L, Livrea P, Trojano M. Giorelli M, et al. Among authors: livrea p. Cell Commun Adhes. 2002 Sep-Dec;9(5-6):259-72. doi: 10.1080/15419060216305. Cell Commun Adhes. 2002. PMID: 12745437 Free article.

8

Interferon beta in relapsing-remitting multiple sclerosis: an independent postmarketing study in southern Italy.

Trojano M, Liguori M, Paolicelli D, Zimatore GB, De Robertis F, Avolio C, Giuliani F, Fuiani A, Livrea P; Southern Italy MS Group. Trojano M, et al. Among authors: livrea p. Mult Scler. 2003 Oct;9(5):451-7. doi: 10.1191/1352458503ms948oa. Mult Scler. 2003. PMID: 14582768 Clinical Trial.

9

Dopamine fails to regulate activation of peripheral blood lymphocytes from multiple sclerosis patients: effects of IFN-beta.

Giorelli M, Livrea P, Trojano M. Giorelli M, et al. Among authors: livrea p. J Interferon Cytokine Res. 2005 Jul;25(7):395-406. doi: 10.1089/jir.2005.25.395. J Interferon Cytokine Res. 2005. PMID: 16022584

10

Immunomodulatory properties of increased levels of liver X receptor beta in peripheral blood mononuclear cells from multiple sclerosis patients.

Giorelli M, Livrea P, Minervini MG, Trojano M. Giorelli M, et al. Among authors: livrea p. Exp Neurol. 2007 Apr;204(2):759-66. doi: 10.1016/j.expneurol.2007.01.013. Epub 2007 Jan 24. Exp Neurol. 2007. PMID: 17337267

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters